2022
DOI: 10.1007/s11011-022-00999-2
|View full text |Cite
|
Sign up to set email alerts
|

Emerging targets signaling for inflammation in Parkinson’s disease drug discovery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 178 publications
0
1
0
Order By: Relevance
“…70 (Wang et al, 2022). In Parkinson's disease, inhibition of NLRP3 reduced IL-1β and caspase-1 (Khairnar et al, 2022). In the process of CPP infection, the increase of NLRP3 aided in the rapid clearance of CP (Li et al, 2021).…”
Section: Vol 70mentioning
confidence: 99%
“…70 (Wang et al, 2022). In Parkinson's disease, inhibition of NLRP3 reduced IL-1β and caspase-1 (Khairnar et al, 2022). In the process of CPP infection, the increase of NLRP3 aided in the rapid clearance of CP (Li et al, 2021).…”
Section: Vol 70mentioning
confidence: 99%